Access the full text.
Sign up today, get DeepDyve free for 14 days.
Birger Åstedt, I. Lecander, T. Brodin, Arne Lundblad, K. Löw (1985)
Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and Its Complex Formation with Plasminogen ActivatorThrombosis and Haemostasis, 53
Z. Werb (1978)
Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functionsThe Journal of Experimental Medicine, 147
K. Danø, P. Andreasen, J. Grøndahl-Hansen, Peter Kristensen, L. Nielsen, L. Skriver (1985)
Plasminogen activators, tissue degradation, and cancer.Advances in cancer research, 44
H. Pannekoek, H. Veerman, H. Lambers, P. Diergaarde, C. Verweij, Anton-Jan van, Zonneveld, J. Mourik (1986)
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.The EMBO Journal, 5
M. Greenberg, E. Ziff (1984)
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 311
P. Andreasen, C. Pyke, A. Riccio, P. Kristensen, L. Nielsen, L. Lund, F. Blasi, K. Danø (1987)
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cellsMolecular and Cellular Biology, 7
Richard Fisher, Edmund, Wallert, Gianfranco Grossill, David Thompson, Richard Tizard, Wolf-Dieter Schleuningll (1985)
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.The Journal of biological chemistry, 260 20
D. Collen (1980)
On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 43
N. Busso, D. Belin, C. Failly-Crépin, J. Vassalli (1987)
Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.Cancer research, 47 2
J. Mourik, D. Lawrence, D. Loskutoff (1984)
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.The Journal of biological chemistry, 259 23
B. Littlefield, L. Johnston, D. Manzer, P. Roche (1985)
Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts.Endocrinology, 117 3
J. Vassalli, J. Hamilton, E. Reich (1976)
Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotidesCell, 8
W. Gunzler (1982)
The primary structure of high molecular mass urokinase from human urine, 363
P. Thomas (1980)
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences of the United States of America, 77 9
N. Busso, D. Belin, C. Failly-Crépin, J. Vassalli (1986)
Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids.The Journal of biological chemistry, 261 20
R. Derynck (1990)
Transforming growth factor‐αMolecular Reproduction and Development, 27
M. Karin, A. Haslinger, H. Holtgreve, R. Richards, P. Krauter, H. Westphal, M. Beato (1984)
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA geneNature, 308
A. Wohlwend, D. Belin, J. Vassalli (1987)
Plasminogen activator-specific inhibitors produced by human monocytes/macrophagesThe Journal of Experimental Medicine, 165
C. Genton, E. Kruithof, W. Schleuning (1987)
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cellsThe Journal of Cell Biology, 104
J. Charron, J. Drouin (1986)
Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter.Proceedings of the National Academy of Sciences of the United States of America, 83 23
M. Karin, R. Richards (1982)
Human metallothionein genes—primary structure of the metallothionein-II gene and a related processed geneNature, 299
Olli Saksela (1985)
Plasminogen activation and regulation of pericellular proteolysis.Biochimica et biophysica acta, 823 1
Kruithof, Grazia Nicolosa, Fedor Bachmann (1987)
Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation.Blood, 70 5
K. Yamamoto (1985)
Steroid receptor regulated transcription of specific genes and gene networks.Annual review of genetics, 19
E. Klein, R. Reinke, P. Feigelson, G. Ringold (1987)
Glucocorticoid-regulated expression from the 5'-flanking region of the rat alpha 1-acid glycoprotein gene. Requirement for ongoing protein synthesis.The Journal of biological chemistry, 262 2
E. Berg, E. Sprengers, M. Jaye, W. Burgess, V. Hinsbergh (1987)
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 mRNA IN HUMAN ENDOTHELIAL CELLSThrombosis and Haemostasis, 58
P Coleman, P. Barouski, T. Gelehrter (1982)
The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation.The Journal of biological chemistry, 257 8
J. Hamilton, A. Bootes, P. Phillips, J. Slywka (1981)
Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.Arthritis and rheumatism, 24 10
D. Crutchley, L. Conanan, J. Maynard (1981)
HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS *Annals of the New York Academy of Sciences, 370
G. Shaw, R. Kamen (1986)
A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 46
Tor Ny, M. Sawdey, Daniel Lawrence, José Millán, D. Loskutoff (1986)
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.Proceedings of the National Academy of Sciences of the United States of America, 83 18
R. Mira‐Y‐Lopez, E. Reich, R. Stolfi, D. Martin, L. Ossowski (1985)
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma.Cancer research, 45 5
G. Markus (1984)
The Role of Hemostasis and Fibrinolysis in the Metastatic Spread of CancerSeminars in Thrombosis and Hemostasis, 10
P Bosma, E. Berg, T. Kooistra (1987)
ISOLATION OF THE GENE CODING FOR HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI-1)Thrombosis and Haemostasis, 58
E. Reich (1978)
ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS
D. Loskutoff, J. Mourik, L. Erickson, Daniel Lawrence (1983)
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.Proceedings of the National Academy of Sciences of the United States of America, 80 10
M. Altus, D. Pearson, A. Horiuchi, Y. Nagamine (1987)
Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability.The Biochemical journal, 242 2
R. Berlin (1978)
Molecular basis of biological degradative processes
M. Mayer, Z. Finci, M. Chaouat (1986)
Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes.Journal of molecular and cellular cardiology, 18 11
E. Kruithof, J. Vassalli, W. Schleuning, R. Mattaliano, F. Bachmann (1986)
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937.The Journal of biological chemistry, 261 24
P. Andreasen, T. Christensen, Huang Jian-ying, L. Nielsen, E. Wilson, K. Danø (1986)
Hormonal regulation of extracellular plasminogen activators and M r ∼ 54000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodiesMolecular and Cellular Endocrinology, 45
(1982)
Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory
S. Seifert, T. Gelehrter (1978)
Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.Proceedings of the National Academy of Sciences of the United States of America, 75 12
J. Valinsky, E. Reich, N. Douarin (1981)
Plasminogen activator in the bursa of Fabricius: Correlations with morphogenetic remodeling and cell migrationsCell, 25
B. Cwikel, P. Barouski-Miller, P. Coleman, T. Gelehrter (1984)
Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells.The Journal of biological chemistry, 259 11
N. Busso, M. Collart, J. Vassalli, D. Belin (1987)
Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes.Experimental cell research, 173 2
M. Collart, D. Belin, J. Vassalli, P. Vassalli (1987)
Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription.Journal of immunology, 139 3
Keld Dan (1987)
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitorsThe Journal of Cell Biology, 104
I. Jung-Testas, E. Baulieu (1983)
Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor.Experimental cell research, 147 1
T. Astrup, S. Müllertz (1952)
The fibrin plate method for estimating fibrinolytic activity.Archives of biochemistry and biophysics, 40 2
(1985)
Characterization of a macrophagederived plasminogen activator inhibitor
D. Pearson, M. Altus, A. Horiuchi, Y. Nagamine (1987)
Dexamethasone coordinately inhibits plasminogen activator gene expression and enzyme activity in porcine kidney cells.Biochemical and biophysical research communications, 143 1
I. Paek, R. Axel (1987)
Glucocorticoids enhance stability of human growth hormone mRNAMolecular and Cellular Biology, 7
Wolf-Dieter Schleuning, Robert Medcalf, C. Hession, R. Rothenbühler, A. Shaw, Egbert Kruithof (1987)
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cellsMolecular and Cellular Biology, 7
M. Laiho, O. Saksela, O. Saksela, P. Andreasen, J. Keski‐oja, J. Keski‐oja (1986)
Enhanced production and extracellular deposition of the endothelial- type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-betaThe Journal of Cell Biology, 103
F. Grosveld, T. Lund, E. Murray, A. Mellor, H. Dahl, R. Flavell (1982)
The construction of cosmid libraries which can be used to transform eukaryotic cells.Nucleic acids research, 10 21
A. Granelli‐Piperno, E. Reich (1978)
A study of proteases and protease-inhibitor complexes in biological fluidsThe Journal of Experimental Medicine, 148
U. Laemmli (1970)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 227
M. Kopitar, B. Rozman, J. Babnik, V. Turk, D. Mullins, T. Wun (1985)
Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen ActivatorsThrombosis and Haemostasis, 54
M. Karin, R. Andersen, E. Slater, Karen Smith, H. Herschman (1980)
Metallothionein mRNA induction in HeLa cells in response to zinc or dexamethasone is a primary induction responseNature, 286
R. Medcalf, Robert Richards, R. Crawford, John Hamilton (1986)
Suppression of urokinase‐type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti‐inflammatory glucocorticoids.The EMBO Journal, 5
Constitutive gene expression of four components of plasminogen activating enzyme system, urinary and tissue-type plasminogen activator (u-PA and t-PA), plasminogen activator inhibitor 1 (PAI-1) and PAI-2 in HT-1080 human fibrosarcoma cells, was modulated by the synthetic glucocorticoid dexamethasone (Dex, 10(-7) M). More than 90% of u-PA, t-PA and PAI-1 antigen was found in conditioned medium, whereas PAI-2 was mainly cell associated. In 48-h culture supernatants (expressed per 10(6) cells) PAI-1 antigen increased from 350 to 3,300 ng and t-PA from 19 to 38 ng. u-PA and PAI-2 in the same samples decreased from 380 to 46 ng and from 3.5 to 1.8 ng, respectively. Northern blot hybridization and nuclear "Run-on" transcription assays demonstrated that the increase of t-PA and PAI-1 and the decrease of u-PA were associated with equivalent changes of gene template activity. Modulation of u-PA, t-PA and PAI-1 gene expression by Dex was completely blocked by the glucocorticoid antagonist RU 38486, suggesting that all effects were mediated through the glucocorticoid receptor. Cycloheximide, an inhibitor of protein biosynthesis induced a rapid transient increase of t-PA, u-PA and PAI-1 mRNA and a sustained increase of PAI-2 mRNA, but blocked the more long term effects of Dex, suggesting that both constitutive and hormonally regulated maintenance of mRNA steady state levels required protein biosynthesis.
The Journal of Cell Biology – Rockefeller University Press
Published: Mar 1, 1988
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.